Global Cancer Genomic Testing Market Research Report 2022 - Market Study Report

Global Cancer Genomic Testing Market Research Report 2022

Report Format: PDF   |   Report ID: 5515876   |   Published Date: August 2022   |   Pages:  94  

Choose License
Market Analysis and Insights: Global Cancer Genomic Testing Market
The global Cancer Genomic Testing market size is projected to reach US$  million by 2028, from US$  million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Breast Cancer Genomic Testing accounting for % of the Cancer Genomic Testing global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Cancer Genomic Testing market size is valued at US$  million in 2021, while the North America and Europe Cancer Genomic Testing are US$  million and US$  million, severally. The proportion of the North America is  % in 2021, while China and Europe are  % and respectively, and it is predicted that China proportion will reach  % in 2028, trailing a CAGR of  % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR  %,  %, and   % respectively for the next 6-year period. As for the Europe Cancer Genomic Testing landscape, Germany is projected to reach US$  million by 2028 trailing a CAGR of  % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Genomic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Genomic Testing market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Genomic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Genomic Testing market.
Global Cancer Genomic Testing Scope and Market Size
Cancer Genomic Testing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Genomic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Breast Cancer Genomic Testing
    Lung Cancer Genomic Testing
    Blood Cancer Genomic Testing
    Liver Cancer Genomic Testing
    Stomach Cancer Genomic Testing
    Others
Segment by Application
    Hospitals
    Clinics
    Diagnostic Laboratories
    Academic and Research Institutes
    Others
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Myriad Genetics
    Centogene AG
    Color Genomics
    Quest Diagnostics
    23andMe Inc.
    Gene By Gene Ltd.
    LabCorp
    Positive Bioscience
    Bio-Rad Laboratories
    Illumina, Inc.
    Agilent Technologies
    Thermo Fisher Scientific
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Genomic Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Breast Cancer Genomic Testing
        1.2.3 Lung Cancer Genomic Testing
        1.2.4 Blood Cancer Genomic Testing
        1.2.5 Liver Cancer Genomic Testing
        1.2.6 Stomach Cancer Genomic Testing
        1.2.7 Others
    1.3 Market by Application
        1.3.1 Global Cancer Genomic Testing Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Diagnostic Laboratories
        1.3.5 Academic and Research Institutes
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Cancer Genomic Testing Market Perspective (2017-2028)
    2.2 Cancer Genomic Testing Growth Trends by Region
        2.2.1 Cancer Genomic Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Cancer Genomic Testing Historic Market Size by Region (2017-2022)
        2.2.3 Cancer Genomic Testing Forecasted Market Size by Region (2023-2028)
    2.3 Cancer Genomic Testing Market Dynamics
        2.3.1 Cancer Genomic Testing Industry Trends
        2.3.2 Cancer Genomic Testing Market Drivers
        2.3.3 Cancer Genomic Testing Market Challenges
        2.3.4 Cancer Genomic Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Cancer Genomic Testing Players by Revenue
        3.1.1 Global Top Cancer Genomic Testing Players by Revenue (2017-2022)
        3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2017-2022)
    3.2 Global Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Cancer Genomic Testing Revenue
    3.4 Global Cancer Genomic Testing Market Concentration Ratio
        3.4.1 Global Cancer Genomic Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Genomic Testing Revenue in 2021
    3.5 Cancer Genomic Testing Key Players Head office and Area Served
    3.6 Key Players Cancer Genomic Testing Product Solution and Service
    3.7 Date of Enter into Cancer Genomic Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Genomic Testing Breakdown Data by Type
    4.1 Global Cancer Genomic Testing Historic Market Size by Type (2017-2022)
    4.2 Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028)
5 Cancer Genomic Testing Breakdown Data by Application
    5.1 Global Cancer Genomic Testing Historic Market Size by Application (2017-2022)
    5.2 Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Cancer Genomic Testing Market Size (2017-2028)
    6.2 North America Cancer Genomic Testing Market Size by Country (2017-2022)
    6.3 North America Cancer Genomic Testing Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Cancer Genomic Testing Market Size (2017-2028)
    7.2 Europe Cancer Genomic Testing Market Size by Country (2017-2022)
    7.3 Europe Cancer Genomic Testing Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Cancer Genomic Testing Market Size (2017-2028)
    8.2 Asia-Pacific Cancer Genomic Testing Market Size by Country (2017-2022)
    8.3 Asia-Pacific Cancer Genomic Testing Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Cancer Genomic Testing Market Size (2017-2028)
    9.2 Latin America Cancer Genomic Testing Market Size by Country (2017-2022)
    9.3 Latin America Cancer Genomic Testing Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Cancer Genomic Testing Market Size (2017-2028)
    10.2 Middle East & Africa Cancer Genomic Testing Market Size by Country (2017-2022)
    10.3 Middle East & Africa Cancer Genomic Testing Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Myriad Genetics
        11.1.1 Myriad Genetics Company Detail
        11.1.2 Myriad Genetics Business Overview
        11.1.3 Myriad Genetics Cancer Genomic Testing Introduction
        11.1.4 Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022)
        11.1.5 Myriad Genetics Recent Development
    11.2 Centogene AG
        11.2.1 Centogene AG Company Detail
        11.2.2 Centogene AG Business Overview
        11.2.3 Centogene AG Cancer Genomic Testing Introduction
        11.2.4 Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022)
        11.2.5 Centogene AG Recent Development
    11.3 Color Genomics
        11.3.1 Color Genomics Company Detail
        11.3.2 Color Genomics Business Overview
        11.3.3 Color Genomics Cancer Genomic Testing Introduction
        11.3.4 Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022)
        11.3.5 Color Genomics Recent Development
    11.4 Quest Diagnostics
        11.4.1 Quest Diagnostics Company Detail
        11.4.2 Quest Diagnostics Business Overview
        11.4.3 Quest Diagnostics Cancer Genomic Testing Introduction
        11.4.4 Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022)
        11.4.5 Quest Diagnostics Recent Development
    11.5 23andMe Inc.
        11.5.1 23andMe Inc. Company Detail
        11.5.2 23andMe Inc. Business Overview
        11.5.3 23andMe Inc. Cancer Genomic Testing Introduction
        11.5.4 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
        11.5.5 23andMe Inc. Recent Development
    11.6 Gene By Gene Ltd.
        11.6.1 Gene By Gene Ltd. Company Detail
        11.6.2 Gene By Gene Ltd. Business Overview
        11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Introduction
        11.6.4 Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022)
        11.6.5 Gene By Gene Ltd. Recent Development
    11.7 LabCorp
        11.7.1 LabCorp Company Detail
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Cancer Genomic Testing Introduction
        11.7.4 LabCorp Revenue in Cancer Genomic Testing Business (2017-2022)
        11.7.5 LabCorp Recent Development
    11.8 Positive Bioscience
        11.8.1 Positive Bioscience Company Detail
        11.8.2 Positive Bioscience Business Overview
        11.8.3 Positive Bioscience Cancer Genomic Testing Introduction
        11.8.4 Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022)
        11.8.5 Positive Bioscience Recent Development
    11.9 Bio-Rad Laboratories
        11.9.1 Bio-Rad Laboratories Company Detail
        11.9.2 Bio-Rad Laboratories Business Overview
        11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Introduction
        11.9.4 Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022)
        11.9.5 Bio-Rad Laboratories Recent Development
    11.10 Illumina, Inc.
        11.10.1 Illumina, Inc. Company Detail
        11.10.2 Illumina, Inc. Business Overview
        11.10.3 Illumina, Inc. Cancer Genomic Testing Introduction
        11.10.4 Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022)
        11.10.5 Illumina, Inc. Recent Development
    11.11 Agilent Technologies
        11.11.1 Agilent Technologies Company Detail
        11.11.2 Agilent Technologies Business Overview
        11.11.3 Agilent Technologies Cancer Genomic Testing Introduction
        11.11.4 Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022)
        11.11.5 Agilent Technologies Recent Development
    11.12 Thermo Fisher Scientific
        11.12.1 Thermo Fisher Scientific Company Detail
        11.12.2 Thermo Fisher Scientific Business Overview
        11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Introduction
        11.12.4 Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022)
        11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Cancer Genomic Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Breast Cancer Genomic Testing Table 3. Key Players of Lung Cancer Genomic Testing Table 4. Key Players of Blood Cancer Genomic Testing Table 5. Key Players of Liver Cancer Genomic Testing Table 6. Key Players of Stomach Cancer Genomic Testing Table 7. Key Players of Others Table 8. Global Cancer Genomic Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 9. Global Cancer Genomic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 10. Global Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million) Table 11. Global Cancer Genomic Testing Market Share by Region (2017-2022) Table 12. Global Cancer Genomic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 13. Global Cancer Genomic Testing Market Share by Region (2023-2028) Table 14. Cancer Genomic Testing Market Trends Table 15. Cancer Genomic Testing Market Drivers Table 16. Cancer Genomic Testing Market Challenges Table 17. Cancer Genomic Testing Market Restraints Table 18. Global Cancer Genomic Testing Revenue by Players (2017-2022) & (US$ Million) Table 19. Global Cancer Genomic Testing Market Share by Players (2017-2022) Table 20. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021) Table 21. Ranking of Global Top Cancer Genomic Testing Companies by Revenue (US$ Million) in 2021 Table 22. Global 5 Largest Players Market Share by Cancer Genomic Testing Revenue (CR5 and HHI) & (2017-2022) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Cancer Genomic Testing Product Solution and Service Table 25. Date of Enter into Cancer Genomic Testing Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Cancer Genomic Testing Market Size by Type (2017-2022) & (US$ Million) Table 28. Global Cancer Genomic Testing Revenue Market Share by Type (2017-2022) Table 29. Global Cancer Genomic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 30. Global Cancer Genomic Testing Revenue Market Share by Type (2023-2028) Table 31. Global Cancer Genomic Testing Market Size by Application (2017-2022) & (US$ Million) Table 32. Global Cancer Genomic Testing Revenue Market Share by Application (2017-2022) Table 33. Global Cancer Genomic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 34. Global Cancer Genomic Testing Revenue Market Share by Application (2023-2028) Table 35. North America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 38. Europe Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 39. Asia-Pacific Cancer Genomic Testing Market Size by Region (2017-2022) & (US$ Million) Table 40. Asia-Pacific Cancer Genomic Testing Market Size by Region (2023-2028) & (US$ Million) Table 41. Latin America Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 42. Latin America Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 43. Middle East & Africa Cancer Genomic Testing Market Size by Country (2017-2022) & (US$ Million) Table 44. Middle East & Africa Cancer Genomic Testing Market Size by Country (2023-2028) & (US$ Million) Table 45. Myriad Genetics Company Detail Table 46. Myriad Genetics Business Overview Table 47. Myriad Genetics Cancer Genomic Testing Product Table 48. Myriad Genetics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 49. Myriad Genetics Recent Development Table 50. Centogene AG Company Detail Table 51. Centogene AG Business Overview Table 52. Centogene AG Cancer Genomic Testing Product Table 53. Centogene AG Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 54. Centogene AG Recent Development Table 55. Color Genomics Company Detail Table 56. Color Genomics Business Overview Table 57. Color Genomics Cancer Genomic Testing Product Table 58. Color Genomics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 59. Color Genomics Recent Development Table 60. Quest Diagnostics Company Detail Table 61. Quest Diagnostics Business Overview Table 62. Quest Diagnostics Cancer Genomic Testing Product Table 63. Quest Diagnostics Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 64. Quest Diagnostics Recent Development Table 65. 23andMe Inc. Company Detail Table 66. 23andMe Inc. Business Overview Table 67. 23andMe Inc. Cancer Genomic Testing Product Table 68. 23andMe Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 69. 23andMe Inc. Recent Development Table 70. Gene By Gene Ltd. Company Detail Table 71. Gene By Gene Ltd. Business Overview Table 72. Gene By Gene Ltd. Cancer Genomic Testing Product Table 73. Gene By Gene Ltd. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 74. Gene By Gene Ltd. Recent Development Table 75. LabCorp Company Detail Table 76. LabCorp Business Overview Table 77. LabCorp Cancer Genomic Testing Product Table 78. LabCorp Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 79. LabCorp Recent Development Table 80. Positive Bioscience Company Detail Table 81. Positive Bioscience Business Overview Table 82. Positive Bioscience Cancer Genomic Testing Product Table 83. Positive Bioscience Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 84. Positive Bioscience Recent Development Table 85. Bio-Rad Laboratories Company Detail Table 86. Bio-Rad Laboratories Business Overview Table 87. Bio-Rad Laboratories Cancer Genomic Testing Product Table 88. Bio-Rad Laboratories Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 89. Bio-Rad Laboratories Recent Development Table 90. Illumina, Inc. Company Detail Table 91. Illumina, Inc. Business Overview Table 92. Illumina, Inc. Cancer Genomic Testing Product Table 93. Illumina, Inc. Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 94. Illumina, Inc. Recent Development Table 95. Agilent Technologies Company Detail Table 96. Agilent Technologies Business Overview Table 97. Agilent Technologies Cancer Genomic TestingProduct Table 98. Agilent Technologies Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 99. Agilent Technologies Recent Development Table 100. Thermo Fisher Scientific Company Detail Table 101. Thermo Fisher Scientific Business Overview Table 102. Thermo Fisher Scientific Cancer Genomic TestingProduct Table 103. Thermo Fisher Scientific Revenue in Cancer Genomic Testing Business (2017-2022) & (US$ Million) Table 104. Thermo Fisher Scientific Recent Development Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Global Cancer Genomic Testing Market Share by Type: 2021 VS 2028 Figure 2. Breast Cancer Genomic Testing Features Figure 3. Lung Cancer Genomic Testing Features Figure 4. Blood Cancer Genomic Testing Features Figure 5. Liver Cancer Genomic Testing Features Figure 6. Stomach Cancer Genomic Testing Features Figure 7. Others Features Figure 8. Global Cancer Genomic Testing Market Share by Application in 2021 & 2028 Figure 9. Hospitals Case Studies Figure 10. Clinics Case Studies Figure 11. Diagnostic Laboratories Case Studies Figure 12. Academic and Research Institutes Case Studies Figure 13. Others Case Studies Figure 14. Cancer Genomic Testing Report Years Considered Figure 15. Global Cancer Genomic Testing Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 16. Global Cancer Genomic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 17. Global Cancer Genomic Testing Market Share by Region: 2021 VS 2028 Figure 18. Global Cancer Genomic Testing Market Share by Players in 2021 Figure 19. Global Top Cancer Genomic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Genomic Testing as of 2021) Figure 20. The Top 10 and 5 Players Market Share by Cancer Genomic Testing Revenue in 2021 Figure 21. North America Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. North America Cancer Genomic Testing Market Share by Country (2017-2028) Figure 23. United States Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. Canada Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Europe Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe Cancer Genomic Testing Market Share by Country (2017-2028) Figure 27. Germany Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Cancer Genomic Testing Market Share by Region (2017-2028) Figure 35. China Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Japan Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. South Korea Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Southeast Asia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. India Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Australia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Latin America Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Latin America Cancer Genomic Testing Market Share by Country (2017-2028) Figure 43. Mexico Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Brazil Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Middle East & Africa Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Cancer Genomic Testing Market Share by Country (2017-2028) Figure 47. Turkey Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Saudi Arabia Cancer Genomic Testing Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Myriad Genetics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 50. Centogene AG Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 51. Color Genomics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 52. Quest Diagnostics Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 53. 23andMe Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 54. Gene By Gene Ltd. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 55. LabCorp Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 56. Positive Bioscience Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 58. Illumina, Inc. Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 59. Agilent Technologies Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Cancer Genomic Testing Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research

Can't find what you're looking for about this report?

Submit Query

Go to contact form

Phone Number

1-302-273-0910
Chat with us